psybio

PsyBio Therapeutics (“PsyBio”) is a biotechnology company developing a portfolio of psychoactive compounds targeted for the treatment of mental health challenges and other disorders.

The Company has a collaboration with Miami University, Oxford Ohio where they have filed intellectual property for biosynthesized psilocybin, it’s intermediates, and other molecules.

Recent News

Get the Psybio
Investor’s Kit now.

Compounds

Market Cap

TSX-V: PSYB